Neuromodulation treatment for chronic migraine given CE mark

Chordate Medical Holding AB, a Swedish medtech company, has developed and patented an innovative treatment method: K.O.S. The company’s existing EC-certificate for K.O.S has now been granted an extension with the indication chronic migraine.

Show CommentsClose Comments

Leave a comment

%d bloggers like this: